Evidence map›Paper›PMID 40005415›Full record

Observational studyMedicina (Kaunas, Lithuania)2025

Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.

Lidia Bravve, Maria Kaydan, Georgy Kostyuk

Abstract readObservational Study
In one paragraph

Observational study in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lidia BravvePsychiatric Hospital No. 1 Named After N.A. Alexeev of the Department of Health of Moscow, 115191 Moscow, Russia.ORCID 0000-0001-5380-4406
Maria KaydanPsychiatric Hospital No. 1 Named After N.A. Alexeev of the Department of Health of Moscow, 115191 Moscow, Russia.
Georgy KostyukPsychiatric Hospital No. 1 Named After N.A. Alexeev of the Department of Health of Moscow, 115191 Moscow, Russia.ORCID 0000-0002-3073-6305

Funding

The study was carried out at the expense of funds allocated to carry out work on the state as-signment on the topic "Molecular genetic and neurophysiological predictors of primary psy-chotic disorders" EGISU NIOCTRT reg. No. 123031600072-3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Psychotic DisordersSchizophreniaAcute DiseaseAdultAntipsychotic AgentsFemaleHumansMaleMiddle AgedSARS-CoV-2Antipsychotic Agentsacute schizophrenia-like psychotic disorderCOVID-19psychosis treatmentschizophrenia

Identifiers

PMID40005415
PMCPMC11857278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.